Such an approach may be potentially exploited in NPC by ex vivo overexpression of LMP1 in tumour cells, with the goal of increasing tumour antigen presentation to prime autologous cytotoxic T cells. The gene discussed is PDLIM7; the disease is nasopharyngeal carcinoma.